Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - eculizumab - infusion, solution concentrate - 300 mg / vial - eculizumab 300 mg / vial

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - budesonide, quantity: 400 microgram/actuation - insufflation - excipient ingredients: - treatment of bronchial asthma. indications as at 3 june 1994: treatment of bronchial asthma. may also be used when replacement or reduction in oral steroid therapy is desired.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - eculizumab 300mg;  ;  ;   - solution for infusion - 300mg/30ml - active: eculizumab 300mg       excipient: dibasic sodium phosphate heptahydrate monobasic sodium phosphate monohydrate polysorbate 80 sodium chloride water for injection - soliris® is indicated for the treatment of patients with paroxysmal nocturnal haemoglobinuria (pnh)to reduce haemolysis.

Canada - English - Health Canada

baxter corporation - mannitol; sorbitol - liquid - 500mg; 2.5g - mannitol 500mg; sorbitol 2.5g - irrigating solutions

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

alexion europe sas, france - sebelipase alfa - concentrate for solution for infusion - 2 mg/ml

Australia - English - Department of Health (Therapeutic Goods Administration)

alexion pharmaceuticals australasia pty ltd - selumetinib sulfate, quantity: 30.25 mg (equivalent: selumetinib, qty 25 mg) - capsule, hard - excipient ingredients: carnauba wax; hypromellose; titanium dioxide; carrageenan; shellac; iron oxide red; purified water; iron oxide yellow; tocofersolan; indigo carmine aluminium lake; glyceryl monooleate; potassium chloride; indigo carmine - koselugo is indicated for the treatment of paediatric patients aged 2 years and above, with neurofibromatosis type 1 (nf1) who have symptomatic, inoperable plexiform neurofibromas (pn).

Australia - English - Department of Health (Therapeutic Goods Administration)

alexion pharmaceuticals australasia pty ltd - selumetinib sulfate, quantity: 12.1 mg (equivalent: selumetinib, qty 10 mg) - capsule, hard - excipient ingredients: titanium dioxide; carnauba wax; potassium chloride; iron oxide black; tocofersolan; strong ammonia solution; shellac; propylene glycol; purified water; carrageenan; hypromellose - koselugo is indicated for the treatment of paediatric patients aged 2 years and above, with neurofibromatosis type 1 (nf1) who have symptomatic, inoperable plexiform neurofibromas (pn).

New Zealand - English - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - rocuronium bromide 10mg - solution for injection - 10 mg/ml - active: rocuronium bromide 10mg excipient: acetic acid sodium acetate trihydrate sodium chloride sodium hydroxide water for injection - as an adjunct to general anaesthesia to facilitate tracheal intubation during routine induction, and during rapid sequence induction when suxamethonium is contraindicated

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - rocuronium bromide 1%{relative} - solution for injection - 10 mg/ml - active: rocuronium bromide 1%{relative} excipient: glacial acetic acid nitrogen sodium acetate sodium chloride sodium hydroxide water for injection - as an adjunct to general anaesthesia to facilitate tracheal intubation during routine induction, and during rapid sequence induction when suxamethonium is contraindicated as an adjunct in the intensive care unit (icu) to facilitate intubation and mechanical ventilation

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - rocuronium bromide 10 mg/ml;   - solution for injection - 10 mg/ml - active: rocuronium bromide 10 mg/ml   excipient: glacial acetic acid sodium acetate trihydrate sodium chloride water for injection - rocuronium is indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during routine induction, to provide muscle relaxation and to facilitate mechanical ventilation in adults, and paediatric patients from term newborn infants to adolescents. in adults, rocuronium is also indicated as an adjunct to general anaesthesia to facilitate endotracheal intubation during rapid sequence induction when suxamethonium is contraindicated. in adults, rocuronium is also indicated as an adjunct in the intensive care unit (icu) to facilitate mechanical ventilation.